Ovagen

Ovagen, also known by its sequence Glu–Asp–Leu (EDL), is classified among the short regulatory peptides that are proposed to act as genome-level bioregulators. Within this conceptual framework, these compounds are often referred to as cytomedines, aka peptide messengers that may operate as independent signaling molecules, helping cells adapt their functional programs to internal and external cues. Within this broader family, Ova-gen has been described by experts as a tripeptide that may form complexes with d(ATATATATAT )sequences located in the minor groove of DNA.

Ovagen

It is proposed that this peptide may bind preferentially to AT-rich stretches of mammalian DNA in the minor groove, where many regulatory interactions usually occur. Through these types of interactions, Ovagen is suggested to interact with the expression of genes encoding cellular aging markers and other regulators of cellular stress responses. In vitro data from renal and hepatic models further suggest that Ova-gen may display protective potential, possibly by modulating gene expression programs linked to proliferation, redox balance, and cellular resilience.